ADORA2A and gastric cancer: There is a great need to better understand the role of CD73 and Adora2b in gastric cancer, whether blocking adenosine signaling through inhibition of CD73 and/or Adora2a/Adora2b antagonism improves the potential for anti-tumor immunity in gastric cancer.